MJ Silver

630 total citations
21 papers, 496 citations indexed

About

MJ Silver is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Molecular Biology. According to data from OpenAlex, MJ Silver has authored 21 papers receiving a total of 496 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 7 papers in Hematology and 4 papers in Molecular Biology. Recurrent topics in MJ Silver's work include Platelet Disorders and Treatments (7 papers), Antiplatelet Therapy and Cardiovascular Diseases (7 papers) and Phagocytosis and Immune Regulation (3 papers). MJ Silver is often cited by papers focused on Platelet Disorders and Treatments (7 papers), Antiplatelet Therapy and Cardiovascular Diseases (7 papers) and Phagocytosis and Immune Regulation (3 papers). MJ Silver collaborates with scholars based in United States, Italy and Poland. MJ Silver's co-authors include S Murphy, Giovanni Di Minno, David L. Turner, J. Bryan Smith, Sandor S. Shapiro, CM Ingerman, Albert W. Sedar, Leandro M. Tocantins, S. F. Herb and F. E. Luddy and has published in prestigious journals such as Nature, Blood and Journal of Medicinal Chemistry.

In The Last Decade

MJ Silver

21 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
MJ Silver United States 10 220 167 115 81 74 21 496
Marcus E. McKenzie United States 8 144 0.7× 113 0.7× 40 0.3× 52 0.6× 128 1.7× 11 351
PB Kernoff United Kingdom 12 52 0.2× 431 2.6× 47 0.4× 92 1.1× 70 0.9× 21 822
Marcial Martı́nez Spain 10 128 0.6× 94 0.6× 30 0.3× 99 1.2× 21 0.3× 22 509
Maurizio De Caterina Italy 15 143 0.7× 67 0.4× 21 0.2× 79 1.0× 49 0.7× 30 618
Michael J. Haut United States 10 89 0.4× 119 0.7× 15 0.1× 37 0.5× 12 0.2× 20 472
R. Gross Germany 13 34 0.2× 108 0.6× 28 0.2× 51 0.6× 26 0.4× 67 487
Jana Matusková Slovakia 11 208 0.9× 143 0.9× 21 0.2× 110 1.4× 11 0.1× 16 577
H. M. Tyler United Kingdom 14 146 0.7× 83 0.5× 98 0.9× 85 1.0× 5 0.1× 29 488
Peter Grešner Poland 15 123 0.6× 41 0.2× 75 0.7× 54 0.7× 14 0.2× 25 558
Valeria Zuliani Italy 10 111 0.5× 22 0.1× 100 0.9× 67 0.8× 41 0.6× 17 376

Countries citing papers authored by MJ Silver

Since Specialization
Citations

This map shows the geographic impact of MJ Silver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MJ Silver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MJ Silver more than expected).

Fields of papers citing papers by MJ Silver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MJ Silver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MJ Silver. The network helps show where MJ Silver may publish in the future.

Co-authorship network of co-authors of MJ Silver

This figure shows the co-authorship network connecting the top 25 collaborators of MJ Silver. A scholar is included among the top collaborators of MJ Silver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MJ Silver. MJ Silver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saffari, Ayden & MJ Silver. (2017). DNA methylation in children from The Gambia. London School of Hygiene & Tropical Medicine. 1 indexed citations
2.
Silver, MJ, et al.. (1986). Trial of repeated low-dose aspirin in diabetic angiopathy. Blood. 68(4). 886–891. 7 indexed citations
3.
Silver, MJ, et al.. (1986). Trial of repeated low-dose aspirin in diabetic angiopathy. Blood. 68(4). 886–891. 61 indexed citations
4.
Silver, MJ, et al.. (1985). Increased binding of fibrinogen to platelets in diabetes: the role of prostaglandins and thromboxane. Blood. 65(1). 156–162. 46 indexed citations
5.
Silver, MJ, et al.. (1985). Increased binding of fibrinogen to platelets in diabetes: the role of prostaglandins and thromboxane. Blood. 65(1). 156–162. 4 indexed citations
6.
Beebe, David C., et al.. (1985). Control of lens cell differentiation and ion fluxes by growth factors. Cell Differentiation. 16. 78–78. 6 indexed citations
7.
Silver, MJ, et al.. (1983). Monitoring the entry of new platelets into the circulation after ingestion of aspirin. Blood. 61(6). 1081–1085. 11 indexed citations
8.
Minno, Giovanni Di, MJ Silver, & S Murphy. (1983). Monitoring the entry of new platelets into the circulation after ingestion of aspirin. Blood. 61(6). 1081–1085. 113 indexed citations
9.
Silver, MJ, et al.. (1982). Stored human platelets retain full aggregation potential in response to pairs of aggregating agents. Blood. 59(3). 563–568. 107 indexed citations
10.
Silver, MJ, et al.. (1982). Stored human platelets retain full aggregation potential in response to pairs of aggregating agents. Blood. 59(3). 563–568. 1 indexed citations
11.
Ingerman, CM, J. Bryan Smith, Sandor S. Shapiro, Albert W. Sedar, & MJ Silver. (1978). Hereditary abnormality of platelet aggregation attributable to nucleotide storage pool deficiency. Blood. 52(2). 332–344. 40 indexed citations
12.
Ingerman, CM, et al.. (1978). Hereditary abnormality of platelet aggregation attributable to nucleotide storage pool deficiency. Blood. 52(2). 332–344. 30 indexed citations
13.
Silver, MJ. (1970). Platelet aggregation and plug formation: a model test system. American Journal of Physiology-Legacy Content. 218(2). 384–388. 4 indexed citations
14.
Silver, MJ. (1970). Platelet aggregation and plug formation: studies on mechanism of action. American Journal of Physiology-Legacy Content. 218(2). 389–395. 6 indexed citations
15.
Turner, David L., et al.. (1968). The total synthesis of phosphatidyl(Dioleoyl)hydroxy‐l‐proline and its activity in blood‐clotting systems. Lipids. 3(3). 228–233. 5 indexed citations
16.
Turner, David L., et al.. (1966). The total synthesis of dilinoleoylphosphatidylserine and its activity in blood clotting systems. Lipids. 1(6). 439–443. 9 indexed citations
17.
Turner, David L., et al.. (1966). Total Synthesis of Unsaturated Phosphatidylserine Using the N-4-Chlorobutyroyl Protecting Group1. Journal of Medicinal Chemistry. 9(5). 771–772. 2 indexed citations
18.
Silver, MJ, et al.. (1963). Evaluation of Activity of Phospholipids in Blood Coagulation in Vitro. Thrombosis and Haemostasis. 10(1). 164–189. 16 indexed citations
19.
Turner, David L. & MJ Silver. (1963). Total Synthesis of Unsaturated Phosphatidylserine and its Activity in Clotting Systems. Nature. 200(4904). 370–371. 10 indexed citations
20.
Turner, David L., MJ Silver, & Leandro M. Tocantins. (1958). Phospholipide antithromboplastin. II. Preparation and properties. Archives of Biochemistry and Biophysics. 77(2). 249–257. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026